QED | BridgeBio Research | Achondroplasia Research
SponsoredPROPEL is a clinical program evaluating infigratinib in achondroplasia. Visit the we…Focus on Patient Outcomes · Global Clinical Trials · Focused on Growth
Study Types: Phase 3 Trials, Interventional Studies, Double-Blind Trials and more

Feedback